Skip to main content

Table 2 Comparison of upgraded or nonupgraded cases within different PIRADS score groups

From: The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy

 

Upgrade

Non-upgrade

Total n(%)

p value

ISUP1 + PIRADS5

43 (70.5%)

18 (29.5%)

61 (100%)

0.016

ISUP1 + PIRADS4

54 (62.7%)

32 (37%)

86 (100%)

0.062

ISUP1 + PIRADS3

12 (44%)

15 (55%)

27 (100%)

0.086